10:00 – 11:00 AM | Paris Brussels |
2:30 – 3:30 PM | India |
4:00 – 5:00 PM | Indonesia Thailand Vietnam |
5:00 – 6:00 PM | China Singapore |
6:00 – 7:00 PM | Japan Korea |
1:00 – 2:00 AM | San Francisco |
4:00 – 5:00 AM | New York |
Session 1: 10:00 AM CET, 4:00 AM ESTDuration: 1 HourRegister Now |
Session 2: 5:00 PM CET, 11:00 AM ESTDuration: 1 HourRegister Now |
QbD (Quality by Design) is of growing importance to the pharmaceutical industry – both for novel drugs and generics. Driven by health authorities worldwide, pharmaceutical manufacturers are under increasing pressure to implement QbD principles and thereby increase control over product quality. This also impacts excipient supply.
This webinar outlines how excipient suppliers can support these QbD efforts. User-supplier cooperation is essential in controlling critical parameters once these have been defined. Defining the design space requires QbD samples – are these available, and what can be done if not? The webinar shows a way out of this trap.
Dr. Leo Ohrem, Portfiolio Manager Solid Dose
|